Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice
Lucas Opazo-Ríos(Austral University of Chile), Sebastián Mas(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas)
Cited by 14
Related Papers
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease
|International Journal of Molecular Sciences|2024|37
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy
|International Journal of Molecular Sciences|2020|17